Symptomatic conduction system disease in cardiac amyloidosis

Area of Science:

• Cardiology
• Electrophysiology
• Amyloidosis Research

Background:

• Cardiac amyloidosis is a progressive infiltrative disease affecting the heart.
• Conduction system disease (CSD) can occur in cardiac amyloidosis but is infrequently reported.
• Management strategies for CSD in this patient population are not well-established.

Purpose of the Study:

• To describe the clinical experience of patients with cardiac amyloidosis and symptomatic conduction system disease.
• To report on the outcomes of permanent pacemaker implantation in this cohort.
• To contribute to the understanding of managing conduction abnormalities in cardiac amyloidosis.

Main Methods:

• Retrospective review of patients diagnosed with cardiac amyloidosis.
• Identification of patients with symptomatic conduction system disease.
• Analysis of data pertaining to permanent pacemaker implantation and follow-up.

Main Results:

• Patients with cardiac amyloidosis experienced symptomatic conduction system disease.
• Permanent pacemaker implantation was required for management.
• Outcomes related to pacemaker implantation were observed in the study cohort.

Conclusions:

• Symptomatic conduction system disease is a recognized complication of cardiac amyloidosis.
• Permanent pacemaker implantation is a necessary intervention for select patients.
• Further research is needed to fully elucidate management and outcomes.